@UKLowCarb So you don't know how it's determined. Otvos speculates that in people with dyslipidemia ApoB is so damaged on some LDL that it doesn't register on the ApoB assay. In people w/out dyslipidemia LDL is lower than ApoB. https://t.co/pWKa3WMkYw
RT @fipco: “Debated for decades, the weight of evidence now clearly supports the superiority of apoB over LDL-C or non-HDL-C as the metric…
“Debated for decades, the weight of evidence now clearly supports the superiority of apoB over LDL-C or non-HDL-C as the metric best suited for making individualized lipid-lowering treatment decisions.” (1 author: NIH Lipoprotein Metabolism section head) h
The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B. https://t.co/T7hDFYqaak https://t.co/WJsakg9pjD